Trial Profile
Double-blind, randomized, placebo-controlled, First in Human study of Etc-206 in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Mar 2018
Price :
$35
*
At a glance
- Drugs AUM 001 (Primary)
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 27 Mar 2018 New trial record
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics